Sculptra® Poly‑L‑Lactic Acid (2 x 5 ml)

Sculptra®

Medical device – Biostimulatory dermal filler

Injectable poly\u2011L\u2011lactic acid (PLLA) collagen stimulator

CE‑marked according to EU medical device regulations for injectable PLLA fillers (marketed in EU/UK markets).
Approved by regulatory authorities (e.g. U.S. FDA for Sculptra Aesthetic) for indicated uses in facial volume restoration and soft‑tissue correction.

CE‑marked according to EU medical device regulations for injectable PLLA fillers (marketed in EU/UK markets).
Approved by regulatory authorities (e.g. U.S. FDA for Sculptra Aesthetic) for indicated uses in facial volume restoration and soft‑tissue correction.

Injectable poly\u2011L\u2011lactic acid (PLLA) collagen stimulator

Description

Sculptra® is an injectable biostimulatory filler comprising microparticles of poly‑L‑lactic acid (PLLA), supplied as sterile lyophilised powder in vials. Once reconstituted with sterile water for injection (and optionally lidocaine for comfort), the suspension is injected into deep dermis, subcutaneous tissue or supraperiosteal planes. Over weeks to months, PLLA microparticles stimulate fibroblast activity and collagen synthesis, gradually restoring facial volume, improving skin firmness and smoothness, and reducing wrinkles and folds for a natural, long‑lasting rejuvenation effect.

Bnefits

Stimulates natural collagen production to restore lost facial volume and improve skin structure.
Provides progressive, natural-looking volumising without overfilling — ideal for age‑related volume loss, facial laxity and skin thinning.
Long-lasting results — effects may persist up to 24 months or more with proper treatment plan.
Completely synthetic and biocompatible (non‑animal derived), reducing risk of immunologic reactions associated with foreign tissue fillers.

Indications

Correction of facial volume loss related to ageing or facial fat atrophy (e.g. cheeks, temples, chin, jaws).
Treatment of deep wrinkles, folds and facial contour depressions (e.g. nasolabial folds, marionette lines, pre‑jowl sulcus).
Reconstruction or restoration of facial volume for patients with facial lipoatrophy or soft‑tissue volume deficiency.

Composition

Poly‑L‑lactic acid (PLLA) microparticles — lyophilised powder in each vial.
Sodium carboxymethylcellulose (USP) — used as a suspending agent.
Non‑pyrogenic Mannitol (USP) — stabiliser in lyophilised powder.
Sterile water for injection (SWFI) added upon reconstitution; optional addition of lidocaine for comfort prior to injection.